Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 2:50 pm Sale | 13G | ESSA PHARMA INC EPIX | EVENTIDE ASSET MANAGEMENT LLC | 0 0% | -3,318,647 (Position Closed) | View |
2023-02-14 2:37 pm Sale | 13G | ZYMEWORKS INC ZYME | EVENTIDE ASSET MANAGEMENT LLC | 0 0% | -2,819,135 (Position Closed) | View |
2023-02-14 2:06 pm Purchase | 13G | VECTIVBIO HLDG AG VECT | EVENTIDE ASSET MANAGEMENT LLC | 3,405,644 5.4% | 1,066,600 (+45.60%) | View |
2023-02-14 1:58 pm Sale | 13G | PROMETHEUS BIOSCIENCES INC RXDX | EVENTIDE ASSET MANAGEMENT LLC | 1,032,938 2.2% | -2,709,569 (-72.40%) | View |
2023-02-14 1:54 pm Purchase | 13G | FREELINE THERAPEUTICS HLDGS FRLN | EVENTIDE ASSET MANAGEMENT LLC | 5,920,765 9.1% | 2,435,109 (+69.86%) | View |
2023-02-14 1:48 pm Sale | 13G | COGENT BIOSCIENCES INC COGT | EVENTIDE ASSET MANAGEMENT LLC | 2,589,778 3.7% | -925,131 (-26.32%) | View |
2023-02-14 1:40 pm Purchase | 13G | ANNEXON INC ANNX | EVENTIDE ASSET MANAGEMENT LLC | 3,626,508 7.6% | 776,508 (+27.25%) | View |
2023-02-14 1:38 pm Sale | 13G | PRAXIS PRECISION MEDICINES INC PRAX | EVENTIDE ASSET MANAGEMENT LLC | 3,518,062 7.5% | -292,537 (-7.68%) | View |
2023-02-14 1:36 pm Sale | 13G | KNOWBE4 INC CLASS A KNBE | EVENTIDE ASSET MANAGEMENT LLC | 0 0% | -4,177,983 (Position Closed) | View |
2023-02-14 1:34 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | EVENTIDE ASSET MANAGEMENT LLC | 2,057,000 5.6% | 2,057,000 (New Position) | View |
2023-02-14 1:32 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | EVENTIDE ASSET MANAGEMENT LLC | 3,150,000 6.6% | 3,150,000 (New Position) | View |
2023-02-14 1:30 pm Purchase | 13G | AURA BIOSCIENCES INC AURA | EVENTIDE ASSET MANAGEMENT LLC | 2,251,368 6.3% | 2,251,368 (New Position) | View |
2023-02-14 1:24 pm Purchase | 13G | 908 DEVICES INC MASS | EVENTIDE ASSET MANAGEMENT LLC | 2,230,665 7% | 2,230,665 (New Position) | View |
2022-02-14 12:04 pm Purchase | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | EVENTIDE ASSET MANAGEMENT LLC | 2,629,593 7.6% | 201,617 (+8.30%) | View |
2022-02-14 12:01 pm Purchase | 13G | VITAL FARMS INC VITL | EVENTIDE ASSET MANAGEMENT LLC | 2,950,000 7.3% | 896,768 (+43.68%) | View |
2022-02-14 12:00 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | EVENTIDE ASSET MANAGEMENT LLC | 2,708,975 5.9% | 338,000 (+14.26%) | View |
2022-02-14 11:57 am Purchase | 13G | PRAXIS PRECISION MEDICINES INC PRAX | EVENTIDE ASSET MANAGEMENT LLC | 3,810,599 8.5% | 297,518 (+8.47%) | View |
2022-02-14 11:55 am Sale | 13G | PLIANT THERAPEUTICS INC PLRX | EVENTIDE ASSET MANAGEMENT LLC | 42,499 0.1% | -2,795,626 (-98.50%) | View |
2022-02-14 11:53 am Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | EVENTIDE ASSET MANAGEMENT LLC | 138,821 0.6% | -1,541,179 (-91.74%) | View |
2022-02-14 11:50 am Sale | 13G | KALA PHARMACEUTICALS INC KALA | EVENTIDE ASSET MANAGEMENT LLC | 0 0% | -3,450,000 (Position Closed) | View |